Search

everythinglearnresearchcommunity

for

Search:↓

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Low vitamin D levels may affect ovulation and progesterone in infertile women.

A nutrition program significantly improved a woman's lupus symptoms.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Metformin and vitamin D3 help manage insulin resistance and hormonal imbalances in obese PCOS patients.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

The foreword introduces a medical issue discussing male hormonal health, treatments, and the effects of conditions like obesity and aging.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

Hormonal therapy in adults with gender dysphoria often leads to skin issues like acne, requiring a team of skin and hormone doctors.

Women with androgenetic alopecia often have other symptoms of high androgen levels, requiring further hormone testing.

Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.

Monilethrix causes short, fragile hair with no specific treatment available.

Removing the ovarian tumor improved the woman's hormonal symptoms.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Always consider xanthomatous hypophysitis before deciding on pituitary surgery.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

The patient with a misplaced pituitary gland and interrupted pituitary stalk is being treated with hormone replacement.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.

A boy with a new NR5A1 gene mutation has a sex development disorder without affecting his adrenal glands.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

A woman's masculine symptoms were caused by a rare tumor in her left ovary, which was found using a special blood test.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

A woman's ovarian fibroma caused high testosterone levels, which normalized after surgery.

A woman was diagnosed with Sheehan's syndrome and a rare complication of diabetes insipidus 33 years after symptoms began, improving with hormone therapy.